PrescriptSure, Inc. — SEC Form D Filing
PrescriptSure, Inc. filed an SEC Form D on September 22, 2026, reporting $250K raised in Healthcare Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- September 22, 2026
- Amount reported
- $250K
- Round stage
- Pre-Seed
- Industry
- Healthcare Technology
- Website
- https://prescriptsure.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Outpatient practices face significant inefficiencies and staff workload due to rejected prescriptions, coverage surprises, and prior authorization issues, leading to delays in patient care and numerous pharmacy callbacks.
Solution
PrescriptSure provides a tool that allows healthcare teams to verify prescription coverage, check prior authorization requirements, and identify covered alternatives before sending prescriptions, thereby avoiding pharmacy callbacks and staff follow-up.
Why now
Healthcare systems and outpatient practices are under increasing pressure to improve efficiency and reduce administrative burden, making solutions that streamline prescription workflows highly valuable.
Verdict
This cleared because investors saw a high-frequency, painful administrative problem with a direct software solution, not because it promised a revolutionary shift in healthcare. They were implicitly betting on capturing a segment of the existing healthcare IT budget by selling a workflow optimization tool that offered immediate, measurable efficiency gains to clinic administrators. The upside was limited by the relatively small addressable market for a point solution and the potential for larger EHR vendors or existing infrastructure players to integrate similar functionalities, making it a feature rather than a standalone platform.
Source: SEC EDGAR Form D filing